ONCOLOGY
Advancing Oncology Therapies with Precision Chemistry and Purpose-Built Manufacturing Oncology drug development demands exceptional control, specialized infrastructure, and teams experienced in handling complex, potent, and sensitive molecules. LMS brings all three together supporting with a purpose-built HPAPI manufacturing platform designed for high-complexity small-molecule programs from development through commercialization.
PURPOSE-BUILT HPAPI FACILITY
- High-containment suites designed for handling OEL < 1 µg/m³
- Flexible reactor configurations ranging from 250L - 2000L with isolator capabilities
- Integrated process development and quality control labs
- Dedicated cleanroom pathways minimizing cross-contamination
- Validated containment protocols across development and production
QUALITY, SAFETY & COMPLIANCE AT THE CORE
- Containment strategy mapping for each process
- Continuous operator exposure monitoring
- Data integrity–aligned digital systems
- GMP manufacturing with validated cleaning and segregation protocols
- Full traceability and batch documentation for global submissions
WHY LMS
- Dedicated HPAPI/Oncology facility with advanced containment
- Proven capability in complex, multi-step oncology synthesis
- Integrated development-to-commercial pathway
- Strong quality systems and regulatory alignment
- Reliable supply and collaborative project management
- Trusted partner to leading global pharma companies
FAQs
What types of oncology molecules does LMS specialize in?
What containment levels can LMS handle?
Can LMS manufacture both oncology intermediates and final APIs?
Does LMS support tech transfer and process optimization for oncology programs?
What scales can LMS support for oncology and HPAPI products?
Can LMS support regulatory submissions for oncology products?
Close